Medical/Pharmaceuticals

Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study

CHENGDU, China, March 18, 2026 /PRNewswire/ -- The 2026 European Lung Cancer Congress (ELCC) will be held in Copenhagen, Denmark, from March 25 to 28, 2026 (local time). At this congress, the final OS analysis from the pivotal study (OptiTROP-Lung03) of sacituzumab tirumotecan (sac-TMT, also know...

2026-03-18 22:31 9558

Picarro Launches PI2124 Hydrogen Peroxide Analyzer to Improve VHP Monitoring in Pharmaceutical Manufacturing

Software enhancements strengthen compliance support with better traceability, audit readiness, and operational efficiency SANTA CLARA, Calif., March 18, 2026 /PRNewswire/ -- Picarro Inc.

2026-03-18 22:10 6743

Alphamab Oncology Appoints Mr. Fei Wang as Chief Financial Officer

SUZHOU, China, March 18, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced the appointment of Mr. Fei Wang as Chief Financial Officer (CFO). Mr. Wang will be responsible for the company's capital operations, investment and financing management and investor relations, an...

2026-03-18 21:43 6375

Taiwan's CMUH Achieves World's Only Perfect HIMSS Digital Health Score

TAICHUNG, March 18, 2026 /PRNewswire/ -- China Medical University Hospital (CMUH) has become the only healthcare institution worldwide to achieve a perfect score in the 2025 HIMSS Digital Health Indicator (DHI) assessment, highlighting the accelerating role of digital transformation and artificia...

2026-03-18 20:00 5112

DCwire® Micro Guidewire Receives FDA 510(k) Clearance, Marking a Key Milestone in Peijia Medical's Global Expansion

SUZHOU, China, March 18, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its DCwire® Micro Guidewire has received 510(k) clearance from the U.S. Food and D...

2026-03-18 20:00 4745

SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

* Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody * Technology licensed from Gates MRI; early studies confirm suppression of RSV infection * Targeting global markets while addressing unmet needs in developing countries INCHEON, South...

2026-03-18 20:00 8670

Avid Organics to Launch the World's First Commercial-Scale Bio-Based Glycolic Acid, AviGa™ Bio HP70, at in-cosmetics® Global in Paris

* AviGa™ Bio HP70 is a bio-based, 70% cosmetic-grade glycolic acid available globally from April 14, 2026, with REACH registration ensuring uninterrupted European supply * The launch marks a pivotal shift for personal care, cosmetics, and pharmaceutical industries by offering a sustainable, t...

2026-03-18 17:27 6897

Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics

* The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of sites globally. * By partnering with Anthropic, Ultima Genomics, and PacBio, and powered by NVIDIA AI infrastructure, Basecamp Research aim...

2026-03-18 17:00 4279

ProtectHealth strengthen PeKa b40 health screening promotion with Hospital Shah Alam staff in Program Ziarah MADANI

SHAH ALAM, Malaysia, March 18, 2026 /PRNewswire/ -- ProtectHealth Corporation Sdn. Bhd., as an implementing agency under the Ministry of Health Malaysia (MOH), continues to strengthen efforts to promote the Skim Peduli Kesihatan for the B40 group during the Program Ziarah MADANI at Hospital Shah ...

2026-03-18 14:26 4721

Innodisk at NVIDIA GTC 2026: Accelerating Real-World AI for Healthcare and Mobility with Full-Stack Edge Solutions

SAN JOSE, Calif., March 18, 2026 /PRNewswire/ -- Innodisk, a leading global AI solution provider, today announced its participation in NVIDIA GTC 2026. Alongside subsidiary Aetina, Innodisk Group is showcasing the seamless integration of NVIDIA AI architectures into scalable, deployable edge AI ...

2026-03-18 11:32 8529

Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited

SHANGHAI, March 18, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a letter of...

2026-03-18 11:07 10908

North London Collegiate School (Singapore) Student Achieves Academic Milestone with Peer-Reviewed Journal Publication

Saket Subramaniam of North London Collegiate School (Singapore) publishes peer-reviewed medical research on colorectal cancer liver metastasis in the American Journal of Student Research. SINGAPORE, March 18, 2026 /PRNewswire/ -- North London Collegiate School (Singapore) celebrates the remarkab...

2026-03-18 10:00 6236

Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs

SHANGHAI and HONG KONG, March 18, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune ...

2026-03-18 08:30 6922

Vieworks to Debut VISQUE DPS LH210 at USCAP 2026, a Single Scanner for Both Cytology and Histology

High-throughput, mid capacity LH210 expands the VISQUE DPS lineup with fast scanning, optimized data size, and scalable digital pathology workflow ANYANG, South Korea, March 18, 2026 /PRNewswire/ -- Vieworks, a global provider of advanced imaging solutions, will participate inUSCAP 2026 (United ...

2026-03-18 07:30 4667

Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy

TAIPEI and SAN DIEGO, March 17, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its first-in-class investigational drug Pidnarule...

2026-03-18 07:00 8384

Zylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-Year

HANGZHOU, China, March 17, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, "Zylox-Tonbridge" or the "Company") today announced its annual results for the year endedDecember 31, 2025. In 2025, the Company delivered another year of strong growth and materially improv...

2026-03-18 00:18 10357

Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases

IN026 is a potential first-in-class mRNA therapy for refractory gout, marking the emergence of a new category of mRNA medicines enabled by Innorna's proprietary mRNA–LNP platform. HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- Innorna, a clinical‑st...

2026-03-17 21:30 3999

Meiwu Technology Co Ltd Announces $14 Million Registered Direct Offering

SHENZHEN, China, March 17, 2026 /PRNewswire/ -- Meiwu Technology Co Ltd (NASDAQ: WNW) (the "Company"), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 6,999,996 of the Company's ordinary shares, no par value each ...

2026-03-17 21:25 7824

Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal

HIGHLIGHTS * Oral presentation on key results from the Co-PSMA (NCT06907641 )[1] Investigator-Initiated Trial (IIT) was delivered by ProfLouise Emmett (St Vincent's Hospital Sydney) at the European Association of Urology (EAU) Congress 2026 on the ...

2026-03-17 21:01 7899

Metabolon Collaborates with The Michael J. Fox Foundation to Advance Multiomic Analyses for Parkinson's Research

Partnership supports expanded biomarker discovery efforts within MJFF's Parkinson's Progression Markers Initiative MORRISVILLE, N.C., March 17, 2026 /PRNewswire/ -- Metabolon , ...

2026-03-17 21:00 4333
1 ... 79808182838485 ... 644